false 0000876427 0000876427 2026-08-11 2026-08-11 0000876427 us-gaap:CommonStockMember 2026-08-11 2026-08-11 0000876427 us-gaap:SeriesDPreferredStockMember 2026-08-11 2026-08-11
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934.

Date of Report (Date of Earliest Event Reported): August 11, 2026

 

 

MONRO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

New York   001-42950   16-0838627

(State

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

295 Woodcliff Drive, Suite 202, Fairport, NY   14450
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code (800) 876-6676

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $.01 per share   MNRO   The Nasdaq Stock Market
Rights to Purchase Series D Junior Participating Serial Preferred Stock   MNRO   The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.07

Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders (“Annual Meeting”) of the Company was held on August 11, 2026. At the Annual Meeting, the Company’s holders of common stock voted on each of the matters described below. Approximately 27,722,871 shares (representing 88.72% of total shares of common stock outstanding and entitled to vote) were present at the Annual Meeting either in person or by proxy.

1. The Company’s shareholders elected the following eight directors to the Board of Directors to serve a one-year term and until their successors have been duly elected and qualified at the 2027 Annual Meeting of Shareholders. The number of shares of common stock that (i) voted for the election of each director and (ii) withheld authority to vote for each director, as well as the number of broker non-votes, are set forth in the table below.

 

Nominee  

Votes For

 

Votes Withheld

 

Broker

Non-Votes

Peter D. Fitzsimmons

  20,267,962   5,314,690   2,140,219

Lindsay N. Hyde

  16,787,880   8,794,772   2,140,219

Leah C. Johnson

  19,576,308   6,006,344   2,140,219

Stephen C. McCluski

  16,695,404   8,887,248   2,140,219

Robert E. Mellor

  15,238,939   10,343,713   2,140,219

Thomas B. Okray

  19,676,606   5,906,046   2,140,219

Peter J. Solomon

  19,546,301   6,036,351   2,140,219

Hope B. Woodhouse

  19,651,627   5,931,025   2,140,219

2. The Company’s shareholders voted to approve, on an advisory basis, the compensation paid to the Company’s named executive officers. The number of shares of common stock that voted for or against, or that abstained from voting on, the compensation paid to the Company’s named executive officers, as well as the number of broker non-votes, are set forth in the table below.

 

Votes For

 

Votes Against

 

Abstentions

 

Broker

Non-Votes

18,483,090   1,829,602   5,269,960   2,140,219

3. The Company’s shareholders ratified the re-appointment of PricewaterhouseCoopers, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 27, 2027. The number of shares of common stock that voted for or against, or that abstained from voting for, the ratification of the re-appointment of PricewaterhouseCoopers, LLP are summarized in the table below.

 

Votes For

 

Votes Against

 

Abstentions

21,678,339   900,051   5,144,481

 


Item 8.01

Other Events.

On August 11, 2026, the Board of Directors declared a quarterly cash dividend of $.28 per share for the second quarter of the Company’s 2027 fiscal year, ending March 27, 2027. The dividend is payable on September 8, 2026, to shareholders of record as of August 25, 2026. A copy of the press release announcing the quarterly cash dividend is furnished herewith as Exhibit 99.1.

 

Item 9.01

Financial Statements and Exhibits

 

  (d)

The following is a list of exhibits furnished with this Current Report on Form 8-K:

 

Exhibit

No.

   Description
99.1    Press release dated August 13, 2026.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      MONRO, INC.
      (Registrant)
August 13, 2026     By:  

/s/ Maureen E. Mulholland

      Maureen E. Mulholland,
      Executive Vice President – Chief Legal Officer and Secretary

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-99.1

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: d143308d8k_htm.xml